Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Booth

Showing results (901-910 of 931) with videos related to

Pageof 94
Sort By:
Journal of Cancer Policy|November 29, 2023
Challenges in building radiotherapy capacity: A longitudinal study evaluating eight years of the Brazilian radiotherapy expansion planAndre G Gouveia, Gustavo A Viani, Vanessa F Bratti, et al.
The Lancet. Oncology|September 4, 2025
Importance of responder criteria for reporting health-related quality-of-life data in clinical trials for advanced cancer: recommendations of Common Sense Oncology and the European Organisation for Research and Treatment of CancerIan F Tannock, Madeline Lee Pe, Christopher M Booth, et al.
The Lancet. Oncology|February 6, 2025
Common Sense Oncology principles for the design, analysis, and reporting of phase 3 randomised clinical trialsBishal Gyawali, Elizabeth A Eisenhauer, Winette van der Graaf, et al.
The EMBO Journal|February 25, 2022
Reduced ER-mitochondria connectivity promotes neuroblastoma multidrug resistanceJorida Çoku, David M Booth, Jan Skoda, et al.
Environment International|August 6, 2021
Moving forward in microplastic research: A Norwegian perspectiveAmy L Lusher, Rachel Hurley, Hans Peter H Arp, et al.
Alimentary Pharmacology & Therapeutics|July 9, 2015
Electrical stimulation therapy of the lower oesophageal sphincter for refractory gastro-oesophageal reflux disease - interim results of an international multicentre trialW F W Kappelle, A J Bredenoord, J M Conchillo, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 2, 2021
A Prospective Economic Analysis of Early Outcome Data From the Alliance A041202/ CCTG CLC.2 Randomized Phase III Trial Of Bendamustine-Rituximab Compared With Ibrutinib-Based Regimens in Untreated Older Patients With Chronic Lymphocytic LeukemiaMatthew C Cheung, Nicole Mittmann, Carolyn Owen, et al.
Journal of the National Cancer Institute|January 29, 2026
Effects of a structured exercise program on motivational outcomes in patients with Colon cancerKerry S Courneya, Christopher M Booth, Janette L Vardy, et al.
Leukemia|July 18, 2021
Adverse event burden in older patients with CLL receiving bendamustine plus rituximab or ibrutinib regimens: Alliance A041202Amy S Ruppert, Allison M Booth, Wei Ding, et al.
JAMA Oncology|September 17, 2020
Efficacy and Safety of nab-Paclitaxel vs Paclitaxel on Survival in Patients With Platinum-Refractory Metastatic Urothelial Cancer: The Canadian Cancer Trials Group BL.12 Randomized Clinical TrialSrikala S Sridhar, Normand Blais, Ben Tran, et al.
Pageof 94

Showing results (901-910 of 931) with videos related to

Sort By:
Pageof 94
Journal of Cancer Policy|November 29, 2023
Challenges in building radiotherapy capacity: A longitudinal study evaluating eight years of the Brazilian radiotherapy expansion planAndre G Gouveia, Gustavo A Viani, Vanessa F Bratti, et al.
The Lancet. Oncology|September 4, 2025
Importance of responder criteria for reporting health-related quality-of-life data in clinical trials for advanced cancer: recommendations of Common Sense Oncology and the European Organisation for Research and Treatment of CancerIan F Tannock, Madeline Lee Pe, Christopher M Booth, et al.
The Lancet. Oncology|February 6, 2025
Common Sense Oncology principles for the design, analysis, and reporting of phase 3 randomised clinical trialsBishal Gyawali, Elizabeth A Eisenhauer, Winette van der Graaf, et al.
The EMBO Journal|February 25, 2022
Reduced ER-mitochondria connectivity promotes neuroblastoma multidrug resistanceJorida Çoku, David M Booth, Jan Skoda, et al.
Environment International|August 6, 2021
Moving forward in microplastic research: A Norwegian perspectiveAmy L Lusher, Rachel Hurley, Hans Peter H Arp, et al.
Alimentary Pharmacology & Therapeutics|July 9, 2015
Electrical stimulation therapy of the lower oesophageal sphincter for refractory gastro-oesophageal reflux disease - interim results of an international multicentre trialW F W Kappelle, A J Bredenoord, J M Conchillo, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 2, 2021
A Prospective Economic Analysis of Early Outcome Data From the Alliance A041202/ CCTG CLC.2 Randomized Phase III Trial Of Bendamustine-Rituximab Compared With Ibrutinib-Based Regimens in Untreated Older Patients With Chronic Lymphocytic LeukemiaMatthew C Cheung, Nicole Mittmann, Carolyn Owen, et al.
Journal of the National Cancer Institute|January 29, 2026
Effects of a structured exercise program on motivational outcomes in patients with Colon cancerKerry S Courneya, Christopher M Booth, Janette L Vardy, et al.
Leukemia|July 18, 2021
Adverse event burden in older patients with CLL receiving bendamustine plus rituximab or ibrutinib regimens: Alliance A041202Amy S Ruppert, Allison M Booth, Wei Ding, et al.
JAMA Oncology|September 17, 2020
Efficacy and Safety of nab-Paclitaxel vs Paclitaxel on Survival in Patients With Platinum-Refractory Metastatic Urothelial Cancer: The Canadian Cancer Trials Group BL.12 Randomized Clinical TrialSrikala S Sridhar, Normand Blais, Ben Tran, et al.
Pageof 94